Mach F - Search Results

1

Role of cytokines and chemokines in non-alcoholic fatty liver disease.

Braunersreuther V, Viviani GL, Mach F, Montecucco F. Braunersreuther V, et al. Among authors: mach f. World J Gastroenterol. 2012 Feb 28;18(8):727-35. doi: 10.3748/wjg.v18.i8.727. World J Gastroenterol. 2012. PMID: 22371632 Free PMC article. Review.

2

Update on the role of neutrophils in atherosclerotic plaque vulnerability.

Carbone F, Mach F, Montecucco F. Carbone F, et al. Among authors: mach f. Curr Drug Targets. 2015;16(4):321-33. doi: 10.2174/1389450115666141110093013. Curr Drug Targets. 2015. PMID: 25382205 Review.

3

Follicular regulatory T cell in atherosclerosis.

Baptista D, Mach F, Brandt KJ. Baptista D, et al. Among authors: mach f. J Leukoc Biol. 2018 Nov;104(5):925-930. doi: 10.1002/JLB.MR1117-469R. Epub 2018 Aug 22. J Leukoc Biol. 2018. PMID: 30134501 Review.

4

Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS).

Quercioli A, Mach F, Montecucco F. Quercioli A, et al. Among authors: mach f. Sleep Breath. 2010 Sep;14(3):261-9. doi: 10.1007/s11325-010-0338-3. Epub 2010 Mar 3. Sleep Breath. 2010. PMID: 20198512 Review.

5

Atherosclerosis is an inflammatory disease.

Montecucco F, Mach F. Montecucco F, et al. Among authors: mach f. Semin Immunopathol. 2009 Jun;31(1):1-3. doi: 10.1007/s00281-009-0146-7. Semin Immunopathol. 2009. PMID: 19373464 No abstract available.

6

The role of chemokines in atherosclerosis.

Mach F. Mach F. Curr Atheroscler Rep. 2001 May;3(3):243-51. doi: 10.1007/s11883-001-0067-y. Curr Atheroscler Rep. 2001. PMID: 11286646 Review.

7

Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients.

Montecucco F, Carbone F, Dini FL, Fiuza M, Pinto FJ, Martelli A, Palombo D, Sambuceti G, Mach F, De Caterina R. Montecucco F, et al. Among authors: mach f. Eur J Intern Med. 2014 Nov;25(9):785-94. doi: 10.1016/j.ejim.2014.09.015. Epub 2014 Oct 3. Eur J Intern Med. 2014. PMID: 25283057 Review.

8

Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.

Braunersreuther V, Pellieux C, Pelli G, Burger F, Steffens S, Montessuit C, Weber C, Proudfoot A, Mach F, Arnaud C. Braunersreuther V, et al. Among authors: mach f. J Mol Cell Cardiol. 2010 Apr;48(4):789-98. doi: 10.1016/j.yjmcc.2009.07.029. Epub 2009 Aug 7. J Mol Cell Cardiol. 2010. PMID: 19665464

9

Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability.

Quercioli A, Mach F, Bertolotto M, Lenglet S, Vuilleumier N, Galan K, Pagano S, Braunersreuther V, Pelli G, Pistoia V, Bianchi G, Cittadini G, Viviani GL, Pende A, Roux-Lombard P, Thomas A, Staub C, Ratib O, Dallegri F, Schindler TH, Montecucco F. Quercioli A, et al. Among authors: mach f. Thromb Haemost. 2012 Jan;107(1):124-39. doi: 10.1160/TH11-05-0324. Epub 2011 Nov 24. Thromb Haemost. 2012. PMID: 22116393

10

Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification.

Quercioli A, Luciano Viviani G, Dallegri F, Mach F, Montecucco F. Quercioli A, et al. Among authors: mach f. Crit Pathw Cardiol. 2010 Dec;9(4):227-30. doi: 10.1097/HPC.0b013e318200ec27. Crit Pathw Cardiol. 2010. PMID: 21119343

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results